Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print

Topics - APIs


Refine by Date:
From: To:
Published April 9, 2014
Aims to support long-term growth efforts Read More »
Published April 8, 2014
To provide APIC with additional capacity for APIs and intermediates Read More »
By Kristin Brooks
Published March 24, 2014
Expands custom API products and services Read More »
By Kristin Brooks
Published March 11, 2014
Aims to sell generic Nexium in the U.S., despite regulatory restrictions Read More »
By Gil Roth
Published February 6, 2014
Generic exclusivity boosts 4Q revenues Read More »
By Gil Roth
Published February 5, 2014
First-year goals met Read More »
By Andrew Badrot, CMS Pharma
Published January 30, 2014
DSM & Patheon unlock value through a creative merger Read More »
By Kristin Brooks
Published January 29, 2014
To produce a new class of APIs called viral vectors Read More »
By Kristin Brooks
Published January 27, 2014
Demonstrates proficiency in the safe handling of potent APIs and compounds Read More »
By Gil Roth
Published January 13, 2014
Will lead newly created Commercial Business Unit Read More »
By Kristin Brooks
Published January 9, 2014
Kollidon polymers meet cGMP requirements Read More »
By Gil Roth
Published January 7, 2014
Tests oral Factor Xa inhibitor in Russia Read More »
By Gil Roth
Published December 26, 2013
Plans to boost heparin API position with $337 million purchase Read More »
By Kristin Brooks
Published December 12, 2013
To provide R&D process development and API manufacturing Read More »
By Kristin Brooks
Published December 11, 2013
Excipients and APIs searchable by product name, chemical class Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On